Tandem Diabetes Care
TNDM
TNDM
284 hedge funds and large institutions have $3.24B invested in Tandem Diabetes Care in 2019 Q4 according to their latest regulatory filings, with 58 funds opening new positions, 85 increasing their positions, 101 reducing their positions, and 45 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
7.28% more ownership
Funds ownership: 84.75% → 92.03% (+7.3%)
4% more funds holding
Funds holding: 273 → 284 (+11)
16% less repeat investments, than reductions
Existing positions increased: 85 | Existing positions reduced: 101
Holders
284
Holding in Top 10
8
Calls
$46.2M
Puts
$39.7M
Top Buyers
| 1 | +$89.1M | |
| 2 | +$57.9M | |
| 3 | +$54.2M | |
| 4 |
DM
Deerfield Management
New York
|
+$54.1M |
| 5 |
GGHC
Gilder Gagnon Howe & Co
New York
|
+$36.1M |
Top Sellers
| 1 | -$36.3M | |
| 2 | -$35.5M | |
| 3 | -$33M | |
| 4 |
PWAM
Park West Asset Management
San Francisco,
California
|
-$32.4M |
| 5 |
FAM
Fred Alger Management
New York
|
-$31.4M |